Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Caramia

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|May 11, 2023
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancerRan Li, Sneha Sant, Emmaline Brown, et al.
Breast Cancer Research : BCR|August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patientsCourtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR|July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patientsCourtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hotSimon P Keam, Heloise Halse, Thu Nguyen, et al.
Journal for Immunotherapy of Cancer|May 13, 2022
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatmentAngela Pizzolla, Simon Paul Keam, Ismael A Vergara, et al.
Cancer Research|June 5, 2019
Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho SignalingMariam Mansour, Sue Haupt, Ai-Leen Chan, et al.
Cell Death & Disease|September 8, 2022
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten lossJavier Octavio Mejía-Hernández, Simon P Keam, Reem Saleh, et al.
Cancer Research|May 28, 2016
The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho SignalingMariam Mansour, Sue Haupt, Ai-Leen Chan, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
Plos Medicine|December 28, 2016
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"Peter Savas, Zhi Ling Teo, Christophe Lefevre, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|May 11, 2023
Tucatinib promotes immune activation and synergizes with programmed cell death-1 and programmed cell death-ligand 1 inhibition in HER2-positive breast cancerRan Li, Sneha Sant, Emmaline Brown, et al.
Breast Cancer Research : BCR|August 20, 2020
Clinical implications of prospective genomic profiling of metastatic breast cancer patientsCourtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Breast Cancer Research : BCR|July 15, 2022
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patientsCourtney T van Geelen, Peter Savas, Zhi Ling Teo, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hotSimon P Keam, Heloise Halse, Thu Nguyen, et al.
Journal for Immunotherapy of Cancer|May 13, 2022
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatmentAngela Pizzolla, Simon Paul Keam, Ismael A Vergara, et al.
Cancer Research|June 5, 2019
Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho SignalingMariam Mansour, Sue Haupt, Ai-Leen Chan, et al.
Cell Death & Disease|September 8, 2022
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten lossJavier Octavio Mejía-Hernández, Simon P Keam, Reem Saleh, et al.
Cancer Research|May 28, 2016
The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho SignalingMariam Mansour, Sue Haupt, Ai-Leen Chan, et al.
Nature Communications|September 21, 2017
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancerSathana Dushyanthen, Zhi Ling Teo, Franco Caramia, et al.
Plos Medicine|December 28, 2016
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE"Peter Savas, Zhi Ling Teo, Christophe Lefevre, et al.
Pageof 5